haloperidol and s 16924

haloperidol has been researched along with s 16924 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Audinot, V; Cussac, D; Gobert, A; Lavielle, G; Lejeune, F; Millan, MJ; Muller, O; Newman-Tancredi, A; Nicolas, JP; Rivet, JM1
Bervoets, K; Brocco, M; Dekeyne, A; Lavielle, G; Maurel-Remy, S; Mavridis, M; Millan, MJ; Muller, O; Newman-Tancredi, A; Rivet, JM; Schreiber, R; Sebban, C; Spedding, M1
Brocco, M; Dekeyne, A; Gobert, A; Millan, MJ; Schreiber, R1
Boutin, JA; Cussac, D; Millan, MJ; Newman-Tancredi, A; Nicolas, JP1
Dekeyne, A; Gobert, A; Millan, MJ; Rivet, JM1
Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L1

Other Studies

6 other study(ies) available for haloperidol and s 16924

ArticleYear
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison w
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:3

    Topics: Animals; Antipsychotic Agents; CHO Cells; Clozapine; Cricetinae; Dopamine; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Male; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists

1998
S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and ha
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:3

    Topics: Amphetamines; Animals; Antipsychotic Agents; Attention; Clozapine; Cognition; Discrimination Learning; Electroencephalography; Haloperidol; Humans; Male; Mice; Mice, Inbred ICR; Motor Activity; Prolactin; Pyrrolidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists

1998
S-16924 [(R)-2-[1-[2-(2,3-dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]- pyrrolidin-3yl]-1-(4-fluorophenyl)-ethanone], a novel, potential antipsychotic with marked serotonin1A agonist properties: III. Anxiolytic actions in comparison with clozapine and haloper
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 288, Issue:3

    Topics: Aggression; Animals; Antipsychotic Agents; Autoreceptors; Clorazepate Dipotassium; Clozapine; Columbidae; Conflict, Psychological; Haloperidol; Male; Maze Learning; Mice; Pyrrolidines; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors; Vocalization, Animal

1999
Antagonist properties of the novel antipsychotic, S16924, at cloned, human serotonin 5-HT2C receptors: a parallel phosphatidylinositol and calcium accumulation comparison with clozapine and haloperidol.
    Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:5

    Topics: Animals; Antipsychotic Agents; Calcium; CHO Cells; Clozapine; Cricetinae; Haloperidol; Humans; Phosphatidylinositols; Pyrrolidines; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Transfection; Tritium

2000
Generalization of serotonin (5-HT)1A agonists and the antipsychotics, clozapine, ziprasidone and S16924, but not haloperidol, to the discriminative stimuli elicited by PD128,907 and 7-OH-DPAT.
    Neuropharmacology, 2001, Volume: 40, Issue:7

    Topics: Animals; Antipsychotic Agents; Benzopyrans; Clozapine; Discrimination Learning; Dopamine; Dopamine Agonists; Haloperidol; Humans; Male; Oxazines; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Receptor Agonists; Tetrahydronaphthalenes; Thiazoles

2001
Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.
    European journal of pharmacology, 2001, Oct-05, Volume: 428, Issue:2

    Topics: Animals; Antipsychotic Agents; Binding, Competitive; Chlorpromazine; CHO Cells; Clozapine; Cricetinae; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Membranes; Piperazines; Piperidines; Pyridines; Pyrimidinones; Pyrrolidines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Thiazoles; Thioridazine; Tritium

2001